Wealth Manager - the site for professional investment managers

Register to get unlimited access to Citywire’s fund manager database. Registration is free and only takes a minute.

PRA slams banks and insurers with £11m section 166 costs

PRA slams banks and insurers with £11m section 166 costs

The Prudential Regulation Authority (PRA) issued section 166 orders 33 times since it was set up last April hitting banks and insurers with £11.4 million costs.

In its first report and accounts for the 11 months to the end of February, the PRA said the number of section 166s rose from 27 the previous year although the cost of these fell from £14.7 million in 2012/13.

Nearly half or 16 of the section 166s focused on governance, controls and risk management frameworks, with eight on prudential matters for insurance, seven for deposit takers and clearing houses and two over data and IT infrastructure concerns.

The cost per report ranged from £14,602 to £1.3 million, compared to £33,795 to £3 million in the previous year.

‘Section 166 of FSMA provides a regulatory tool which gives the PRA the powers to obtain an outside expert view of aspects of a firm’s activities that, for example, cause concern or where further analysis is required,’ the banking regulator said.

Overall the PRA spent £202 million of its full year equivalent budget of £230 million. The biggest single cost was the BoE management fee of £59 million, followed by regulatory operations at £42 million, and banking and insurance supervision at £32 million and £30 million, respectively. Transition costs weighed in at £9 million. It has current assets of £33.1 million.

Looking more closely at the PRA, at the end of February, it had 1,045 staff and a staff turnover rate of 11.6% compared to 8.1% for the Bank of England in total. Chief executive Andrew Bailey (pictured) received total remuneration of £340,421 of which £253,127 was his base salary.

Leave a comment!

Please sign in or register to comment. It is free to register and only takes a minute or two.
Citywire TV
Play Biotech Growth: we will ride out this storm

Biotech Growth: we will ride out this storm

Geoffrey Hsu of Biotech Growth Trust says the sell-off in biotechnology stocks represents a buying opportunity for long-term investors.

Play Sector Spotlight: Kleinwort Benson's Choukeir on UK equities

Sector Spotlight: Kleinwort Benson's Choukeir on UK equities

In our first Sector Spotlight of the year we explore UK equities on the back of the extreme market turbulence in 2016.

Play Picton: the UK property hotspots for rental income

Picton: the UK property hotspots for rental income

Picton Property Income CEO Michael Morris reveals how he is planning to ride the ‘ripple effect’ as UK economic growth spills out from the capital across the country.

Your Business: Cover Star Club

Profile: PortfolioMetrix is on a mission to kill 'Frankenstein' systems

Profile: PortfolioMetrix is on a mission to kill 'Frankenstein' systems

In a buyers’ market for off-the-peg discretionary management, self-funded start-ups begin at an inherent disadvantage

Wealth Manager on Twitter